These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 25026302)
1. Hepatic overexpression of the prodomain of furin lessens progression of atherosclerosis and reduces vascular remodeling in response to injury. Lei X; Basu D; Li Z; Zhang M; Rudic RD; Jiang XC; Jin W Atherosclerosis; 2014 Sep; 236(1):121-30. PubMed ID: 25026302 [TBL] [Abstract][Full Text] [Related]
2. Prodomain of Furin Promotes Phospholipid Transfer Protein Proteasomal Degradation in Hepatocytes. Yu Y; Lei X; Jiang H; Li Z; Creemers JWM; Zhang M; Qin S; Jin W; Jiang XC J Am Heart Assoc; 2018 Apr; 7(9):. PubMed ID: 29680823 [TBL] [Abstract][Full Text] [Related]
4. Atherosclerosis-associated hepatic secretion of VLDL but not PCSK9 is dependent on cargo receptor protein Surf4. Wang B; Shen Y; Zhai L; Xia X; Gu HM; Wang M; Zhao Y; Chang X; Alabi A; Xing S; Deng S; Liu B; Wang G; Qin S; Zhang DW J Lipid Res; 2021; 62():100091. PubMed ID: 34118252 [TBL] [Abstract][Full Text] [Related]
5. The peroxisome proliferator-activated receptor alpha (PPARalpha) agonist ciprofibrate inhibits apolipoprotein B mRNA editing in low density lipoprotein receptor-deficient mice: effects on plasma lipoproteins and the development of atherosclerotic lesions. Fu T; Mukhopadhyay D; Davidson NO; Borensztajn J J Biol Chem; 2004 Jul; 279(27):28662-9. PubMed ID: 15123680 [TBL] [Abstract][Full Text] [Related]
6. Human PCSK9 promotes hepatic lipogenesis and atherosclerosis development via apoE- and LDLR-mediated mechanisms. Tavori H; Giunzioni I; Predazzi IM; Plubell D; Shivinsky A; Miles J; Devay RM; Liang H; Rashid S; Linton MF; Fazio S Cardiovasc Res; 2016 May; 110(2):268-78. PubMed ID: 26980204 [TBL] [Abstract][Full Text] [Related]
15. Hepatic Tm6sf2 overexpression affects cellular ApoB-trafficking, plasma lipid levels, hepatic steatosis and atherosclerosis. Ehrhardt N; Doche ME; Chen S; Mao HZ; Walsh MT; Bedoya C; Guindi M; Xiong W; Ignatius Irudayam J; Iqbal J; Fuchs S; French SW; Mahmood Hussain M; Arditi M; Arumugaswami V; Péterfy M Hum Mol Genet; 2017 Jul; 26(14):2719-2731. PubMed ID: 28449094 [TBL] [Abstract][Full Text] [Related]
16. The role of the LDL receptor in apolipoprotein B secretion. Twisk J; Gillian-Daniel DL; Tebon A; Wang L; Barrett PH; Attie AD J Clin Invest; 2000 Feb; 105(4):521-32. PubMed ID: 10683382 [TBL] [Abstract][Full Text] [Related]
17. Hydrogen decreases athero-susceptibility in apolipoprotein B-containing lipoproteins and aorta of apolipoprotein E knockout mice. Song G; Tian H; Qin S; Sun X; Yao S; Zong C; Luo Y; Liu J; Yu Y; Sang H; Wang X Atherosclerosis; 2012 Mar; 221(1):55-65. PubMed ID: 22209213 [TBL] [Abstract][Full Text] [Related]
18. Hepatic gene transfer of the catalytic subunit of the apolipoprotein B mRNA editing enzyme results in a reduction of plasma LDL levels in normal and watanabe heritable hyperlipidemic rabbits. Greeve J; Jona VK; Chowdhury NR; Horwitz MS; Chowdhury JR J Lipid Res; 1996 Sep; 37(9):2001-17. PubMed ID: 8895066 [TBL] [Abstract][Full Text] [Related]
19. Antisense oligonucleotide reduction of apoB-ameliorated atherosclerosis in LDL receptor-deficient mice. Mullick AE; Fu W; Graham MJ; Lee RG; Witchell D; Bell TA; Whipple CP; Crooke RM J Lipid Res; 2011 May; 52(5):885-96. PubMed ID: 21343632 [TBL] [Abstract][Full Text] [Related]
20. LDL Receptor Regulates the Reverse Transport of Macrophage-Derived Unesterified Cholesterol via Concerted Action of the HDL-LDL Axis: Insight From Mouse Models. Cedó L; Metso J; Santos D; García-León A; Plana N; Sabate-Soler S; Rotllan N; Rivas-Urbina A; Méndez-Lara KA; Tondo M; Girona J; Julve J; Pallarès V; Benitez-Amaro A; Llorente-Cortes V; Pérez A; Gómez-Coronado D; Ruotsalainen AK; Levonen AL; Sanchez-Quesada JL; Masana L; Kovanen PT; Jauhiainen M; Lee-Rueckert M; Blanco-Vaca F; Escolà-Gil JC Circ Res; 2020 Aug; 127(6):778-792. PubMed ID: 32495699 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]